AlphaCrest Capital Management’s Repligen RGEN Stock Holding History

AlphaCrest Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,950	Closed	-$365K	–	905
2022 Q3	$365K	Sell	1,950 -2,106	-52%	-$444K	0.02%	1085
2022 Q2	$659K	Buy	4,056 +1,730	+74%	+$274K	0.03%	856
2022 Q1	$437K	Sell	2,326 -2,143	-48%	-$407K	0.02%	957
2021 Q4	$1.18M	Buy	4,469 +2,918	+188%	+$786K	0.04%	715
2021 Q3	$448K	Sell	1,551 -2,666	-63%	-$684K	0.02%	964
2021 Q2	$842K	Buy	4,217 +2,127	+102%	+$413K	0.04%	742
2021 Q1	$406K	Buy	2,090 +316	+18%	+$64.8K	0.02%	900
2020 Q4	$340K	Buy	1,774 +412	+30%	+$75K	0.03%	859
2020 Q3	$201K	Buy	+1,362	New	+$195K	0.02%	1039
2020 Q1	–	Sell	-5,058	Closed	-$468K	–	1236
2019 Q4	$468K	Sell	5,058 -1,156	-19%	-$97.1K	0.04%	827
2019 Q3	$477K	Buy	+6,214	New	+$544K	0.03%	931

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AlphaCrest Capital Management's RGEN Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Repligen (RGEN) in Q4 2022, closing a stake of 1,950 shares — an estimated $365K sold.

AlphaCrest Capital Management first reported a position in RGEN in Q3 2019 and held it in 11 quarters. The position peaked at $1.18M in Q4 2021. 443 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

AlphaCrest Capital Management reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 1,950 Repligen shares in Q4 2022, an estimated $365K.
AlphaCrest Capital Management first reported a position in Repligen in Q3 2019 and held it in 11 quarters.
AlphaCrest Capital Management's Repligen position peaked at $1.18M in Q4 2021.
443 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.